Clinical Trials Directory

Trials / Completed

CompletedNCT03131388

Clinical Performance Evaluation of AMH Assay

Status
Completed
Phase
Study type
Observational
Enrollment
277 (actual)
Sponsor
Beckman Coulter, Inc. · Industry
Sex
Female
Age
21 Years – 45 Years
Healthy volunteers

Summary

The Access AMH Assay is an in vitro diagnostic assay intended as an aid for fertility assessment. The purpose of the study is to evaluate the clinical performance of the Access AMH Assay in the intended use population.

Detailed description

same as brief summary

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTAccess AMH Assay

Timeline

Start date
2016-09-01
Primary completion
2018-04-30
Completion
2018-04-30
First posted
2017-04-27
Last updated
2018-07-13

Locations

13 sites across 2 countries: United States, Canada

Source: ClinicalTrials.gov record NCT03131388. Inclusion in this directory is not an endorsement.

Clinical Performance Evaluation of AMH Assay (NCT03131388) · Clinical Trials Directory